Better glucose and lipid dynamics Even in people without diabetes, GLP-1 medications can improve post-meal metabolic spikes
The FDAs Center for Drug Evaluation and Research (CDER) issued the warning letter after finding issues with how the company reported adverse drug experiences from real patients
Athletes are constantly seeking ways to optimize recovery, performance, and health, but the marketplace is crowded with products that may contain unapproved drugs, contaminants, or undisclosed ingredients
2026-2027 GIC HEALTH INSURANCE INFORMATION *IMPORTANT/ADDRESS CHANGES: If your address has changed, please forward your address change to Sue Powers
This article was created with AI-assisted drafting support and reviewed and edited by the HormoneSynergy team for accuracy, clarity and alignment with its clinical perspective
Nearly all positive human studies have been small, uncontrolled, and authored by people selling the peptide